vs
Orthofix Medical Inc.（OFIX）与Shimmick Corp（SHIM）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Shimmick Corp的1.5倍（$219.9M vs $141.9M），Orthofix Medical Inc.净利率更高（-1.0% vs -3.1%，领先2.1%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-28.7M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -10.1%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
Shimmick Corp是一家总部位于美国的重型民用建筑企业，专注于水处理设施、交通系统、大坝工程、环境修复等关键公共基础设施的建造与升级，主要服务北美各级政府客户，承接各类复杂大型建筑项目。
OFIX vs SHIM — 直观对比
营收规模更大
OFIX
是对方的1.5倍
$141.9M
净利率更高
OFIX
高出2.1%
-3.1%
自由现金流更多
OFIX
多$45.5M
$-28.7M
两年增速更快
OFIX
近两年复合增速
-10.1%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $141.9M |
| 净利润 | $-2.2M | $-4.4M |
| 毛利率 | 71.1% | 7.6% |
| 营业利润率 | 0.2% | -2.2% |
| 净利率 | -1.0% | -3.1% |
| 营收同比 | 2.0% | — |
| 净利润同比 | 92.4% | — |
| 每股收益（稀释后） | $-0.05 | $-0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXSHIM
| Q4 25 | $219.9M | $141.9M | ||
| Q3 25 | $205.6M | $128.4M | ||
| Q2 25 | $203.1M | $122.1M | ||
| Q1 25 | $193.6M | $103.6M | ||
| Q4 24 | $215.7M | — | ||
| Q3 24 | $196.6M | $166.0M | ||
| Q2 24 | $198.6M | $90.6M | ||
| Q1 24 | $188.6M | $120.0M |
净利润OFIXSHIM
| Q4 25 | $-2.2M | $-4.4M | ||
| Q3 25 | $-22.8M | $-8.5M | ||
| Q2 25 | $-14.1M | $-9.8M | ||
| Q1 25 | $-53.1M | $-38.5M | ||
| Q4 24 | $-29.1M | — | ||
| Q3 24 | $-27.4M | $-1.6M | ||
| Q2 24 | $-33.4M | $-51.4M | ||
| Q1 24 | $-36.0M | $-33.3M |
毛利率OFIXSHIM
| Q4 25 | 71.1% | 7.6% | ||
| Q3 25 | 72.2% | 6.3% | ||
| Q2 25 | 68.7% | 3.8% | ||
| Q1 25 | 62.8% | -20.1% | ||
| Q4 24 | 69.0% | — | ||
| Q3 24 | 68.7% | 7.3% | ||
| Q2 24 | 67.8% | -34.4% | ||
| Q1 24 | 67.5% | -13.2% |
营业利润率OFIXSHIM
| Q4 25 | 0.2% | -2.2% | ||
| Q3 25 | -8.3% | -5.5% | ||
| Q2 25 | -7.9% | -7.3% | ||
| Q1 25 | -25.2% | -39.3% | ||
| Q4 24 | -5.3% | — | ||
| Q3 24 | -9.6% | 0.7% | ||
| Q2 24 | -12.5% | -53.0% | ||
| Q1 24 | -15.6% | -26.5% |
净利率OFIXSHIM
| Q4 25 | -1.0% | -3.1% | ||
| Q3 25 | -11.1% | -6.6% | ||
| Q2 25 | -6.9% | -8.0% | ||
| Q1 25 | -27.4% | -37.1% | ||
| Q4 24 | -13.5% | — | ||
| Q3 24 | -13.9% | -0.9% | ||
| Q2 24 | -16.8% | -56.7% | ||
| Q1 24 | -19.1% | -27.8% |
每股收益（稀释后）OFIXSHIM
| Q4 25 | $-0.05 | $-0.12 | ||
| Q3 25 | $-0.57 | $-0.25 | ||
| Q2 25 | $-0.36 | $-0.28 | ||
| Q1 25 | $-1.35 | $-0.92 | ||
| Q4 24 | $-0.76 | — | ||
| Q3 24 | $-0.71 | $-0.05 | ||
| Q2 24 | $-0.88 | $-1.83 | ||
| Q1 24 | $-0.95 | $-1.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $17.6M |
| 总债务越低越好 | — | $57.5M |
| 股东权益账面价值 | $450.0M | $-52.7M |
| 总资产 | $850.6M | $218.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OFIXSHIM
| Q4 25 | $82.0M | $17.6M | ||
| Q3 25 | $62.9M | $21.4M | ||
| Q2 25 | $65.6M | $16.3M | ||
| Q1 25 | $58.0M | $33.7M | ||
| Q4 24 | $83.2M | — | ||
| Q3 24 | $30.1M | $26.0M | ||
| Q2 24 | $26.4M | $22.4M | ||
| Q1 24 | $27.0M | $27.3M |
总债务OFIXSHIM
| Q4 25 | — | $57.5M | ||
| Q3 25 | $157.2M | $36.4M | ||
| Q2 25 | $157.0M | $31.4M | ||
| Q1 25 | $156.9M | $9.5M | ||
| Q4 24 | $157.0M | — | ||
| Q3 24 | $118.5M | $39.9M | ||
| Q2 24 | $118.0M | — | ||
| Q1 24 | $118.2M | $31.5M |
股东权益OFIXSHIM
| Q4 25 | $450.0M | $-52.7M | ||
| Q3 25 | $442.5M | $-49.5M | ||
| Q2 25 | $458.3M | $-42.6M | ||
| Q1 25 | $458.3M | $-34.7M | ||
| Q4 24 | $503.1M | — | ||
| Q3 24 | $525.9M | $973.0K | ||
| Q2 24 | $546.0M | $436.0K | ||
| Q1 24 | $570.3M | $38.1M |
总资产OFIXSHIM
| Q4 25 | $850.6M | $218.5M | ||
| Q3 25 | $832.6M | $203.0M | ||
| Q2 25 | $837.2M | $227.7M | ||
| Q1 25 | $823.1M | $233.9M | ||
| Q4 24 | $893.3M | — | ||
| Q3 24 | $867.9M | $346.7M | ||
| Q2 24 | $882.0M | $344.5M | ||
| Q1 24 | $906.0M | $378.0M |
负债/权益比OFIXSHIM
| Q4 25 | — | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.23× | 41.01× | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | 0.21× | 0.83× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $-23.7M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $-28.7M |
| 自由现金流率自由现金流/营收 | 7.6% | -20.2% |
| 资本支出强度资本支出/营收 | 4.9% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $-27.2M |
8季度趋势，按日历期对齐
经营现金流OFIXSHIM
| Q4 25 | $27.7M | $-23.7M | ||
| Q3 25 | $12.4M | $-3.8M | ||
| Q2 25 | $11.6M | $-38.2M | ||
| Q1 25 | $-18.4M | $44.9M | ||
| Q4 24 | $23.7M | — | ||
| Q3 24 | $11.7M | $12.7M | ||
| Q2 24 | $9.0M | $-43.9M | ||
| Q1 24 | $-18.6M | $-35.0M |
自由现金流OFIXSHIM
| Q4 25 | $16.8M | $-28.7M | ||
| Q3 25 | $2.5M | $-4.2M | ||
| Q2 25 | $4.5M | $-38.7M | ||
| Q1 25 | $-25.1M | $44.4M | ||
| Q4 24 | $15.2M | — | ||
| Q3 24 | $6.3M | $10.3M | ||
| Q2 24 | $-360.0K | $-46.8M | ||
| Q1 24 | $-29.1M | $-39.6M |
自由现金流率OFIXSHIM
| Q4 25 | 7.6% | -20.2% | ||
| Q3 25 | 1.2% | -3.2% | ||
| Q2 25 | 2.2% | -31.7% | ||
| Q1 25 | -13.0% | 42.9% | ||
| Q4 24 | 7.0% | — | ||
| Q3 24 | 3.2% | 6.2% | ||
| Q2 24 | -0.2% | -51.7% | ||
| Q1 24 | -15.4% | -33.0% |
资本支出强度OFIXSHIM
| Q4 25 | 4.9% | 3.5% | ||
| Q3 25 | 4.8% | 0.3% | ||
| Q2 25 | 3.5% | 0.4% | ||
| Q1 25 | 3.5% | 0.5% | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | 2.7% | 1.4% | ||
| Q2 24 | 4.7% | 3.3% | ||
| Q1 24 | 5.6% | 3.8% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
SHIM
| Shimmick Projects | $106.8M | 75% |
| Non Core Projects | $35.1M | 25% |
